RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
APR Applied Pharma Research s.a. and Labtec GmbH announce Ondansetron Oral Dispersible Film ("ODF") is now available for licensing in Europe and selected non European countries
APR and Labtec have regained the marketing and commercialization rights of Ondansetron Oral Dispersible Film (“ODF”) together with the brand name “Setofilm®” after the termination of the former license agreement with the French Company BioAlliance. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Penile Cancer - Pipeline Review, Q1 2011
Jan 2011 - 17 pages - $500
CNS Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Altitude Sickness - Pipeline Review, Q1 2011
Jan 2011 - 17 pages - $500
Hidradenitis Suppurativa - Pipeline Review, Q1 2011
Jan 2011 - 17 pages - $500
Medulloblastoma - Pipeline Review, Q1 2011
Jan 2011 - 19 pages - $500
Poisoning - Pipeline Review, Q1 2011
Jan 2011 - 19 pages - $500
Dyslipidemia - Pipeline Review, Q1 2011
Feb 2011 - 88 pages - $500
Epilepsy - Pipeline Review, Q1 2011
Feb 2011 - 85 pages - $500
Pouchitis - Pipeline Review, Q1 2011
Mar 2011 - 21 pages - $500
HIV-Related Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us